Article
nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infection
2023-04-03
Abstract excerpt
Intranasal treatments, combined with vaccination, has the potential to slow mutational evolution of virusues by reducing transmission and replication. Here we illustrate the development of a SARS-CoV-2 receptor binding domain (RBD) nanoCLAMP and demonstrate its potential as an intranasally administered therapeutic. A multi-epitope nanoCLAMP was made by fusing a pM affinity single-domain nanoCLAMP (P2710) to altern...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5fdf4a2e-7b39-5cda-92eb-cc0b9c82b8bf
- DOI
- 10.1101/2023.04.03.535401
